Abstract
The bZIP transcription factor E4BP4, has been demonstrated to be a survival factor in pro-B lymphocytes. GATA factors play important roles in transducing the IL-3 survival signal and transactivating the downstream survival gene, E4BP4. In heart, GATA sites are essential for proper transcription of several cardiac genes, and GATA-4 is a mediator of cardiomyocyte survival. However, the role E4BP4 plays in heart is still poorly understood. In this study, Dot-blot hybridization assays using Dig-labeled RNA probes revealed that the E4BP4 gene was expressed in cardiac tissue from several species including, monkey, dog, rabbit, and human. Western blot analysis showed that the E4BP4 protein was consistently present in all of these four species. Furthermore, immunohistochemistry revealed that the E4BP4 protein was overexpressed in diseased heart tissue in comparison with normal heart tissue. In addition, the overexpression of E4BP4 in vitro activated cell survival signaling pathway of cardiomyocytes. At last, siRNA-mediated knock down of E4BP4 in zebrafish resulted in malformed looping of the embryonic heart tube and decreased heart beating. Based on these results, we conclude that E4BP4 plays as a survival factor in heart and E4BP4 is essential for proper embryonic heart development.
Similar content being viewed by others
References
Cowell IG (2002) E4BP4/NFIL3, a PAR-related bZIP factor with many roles. Bioessays 24:1023–1029
Cowell IG, Skinner A, Hurst HC (1992) Transcriptional repression by a novel member of the bZIP family of transcription factors. Mol Cell Biol 12:3070–3077
Zhang W, Zhang J, Kornuc M, Kwan K, Frank R, Nimer SD (1995) Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter. Mol Cell Biol 15:6055–6063
Ikushima S, Inukai T, Inaba T, Nimer SD, Cleveland JL, Look AT (1997) Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc Natl Acad Sci USA 94:2609–2614
Yu YL, Chiang YJ, Yen JJY (2002) GATA factors are essential for transcription of the survival gene E4bp4 and the viability response of interleukin-3 in Ba/F3 hematopoietic cells. J Biol Chem 277:27144–27153
Yu YL, Chiang YJ, Chen YC, Papetti M, Juo CG, Skoultchi AI, Yen JJY (2005) MAPK-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival. J Biol Chem 280:29533–29542
Metzstein MM, Hengartner MO, Tsung N, Ellis RE, Horvitz HR (1996) Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2. Nature 382:545–547
Lai CK, Ting LP (1999) Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4. J Virol 73:3197–3209
Nishimura Y, Tanaka T (2001) Calcium-dependent activation of NFIL3/E4BP4 gene expression by calcineurin/NFAT and CaM kinase signaling. J Biol Chem 276:19921–19928
Doi M, Nakajima Y, Okano T, Fukada Y (2001) Light-induced phase-delay of the chicken pineal circadian clock is associated with the induction of cE4bp4, a potential transcriptional repressor of cPer2 gene. Proc Natl Acad Sci USA 98:8089–8094
George H, Terracol R (1997) The vrille gene of Drosophila is a maternal enhancer of decapentaplegic and encodes a new member of the bZIP family of transcription factors. Genetics 146:1345–1363
Cowell IG, Hurst HC (1994) Transcriptional repression by the human bZlP factor E4BP4: definition of a minimal repression domain. Nucleic Acids Res 22:59–65
Cowell IG, Hurst HC (1996) Protein-protein interaction between the transcriptional repressor E4BP4 and the TBP-binding protein Dr1. Nucleic Acids Res 24:3607–3613
Suzuki YJ, Evans T (2004) Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor. Life Sci 74:1829–1838
Park GH, Buetow DE (1991) Genes for insulin-like growth factors I and II are expressed in senescent rat tissues. Gerontology 37:310–316
Huang CY, Kasai M, Buetow DE (1998) Extremely-rapid RNA detection in dot blots with digoxigenin-labeled RNA probes. Genet Anal 4:109–112
Fraysse B, Mons R, Garric J (2006) Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. Ecotoxicol Environ Saf 63:253–267
Carney SA, Prasch AL, Heideman W (2006) Understanding dioxin developmental toxicity using the zebrafish model. Birth Defects Res A Clin Mol Teratol 76:7–18
Barut B, Zon LI (2000) Realizing the potential of zebrafish as a model for human disease. Physiol Genomics 2:49–51
Langheinrich U, Zebrafish (2003) A new model on the pharmaceutical catwalk. Bioessays 25:904–912
Spitsbergen JM, Kent ML (2003) The state of the art of the zebrafish model for toxicology and toxicologic pathology research-advantages and current limitations. Toxicol Pathol 31:62–87
Hill AJ, Teraoka H, Heideman W, Peterson RE (2005) Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 86:6–19
Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic-development of the zebrafish. Dev Dyn 203:253–310
Burggren WW (2004) What is the purpose of the embryonic heart beat? Or how facts can ultimately prevail over physiological dogma. Physiol Biochem Zool 77:333–345
McCormick KM, Dahms NM, Lough J (1996) Insulin-like growth factor-II/mannose-6-phosphate receptor expression during early heart development. Dev Dyn 207:195–203
Bikle DD, Harris J, Halloran BP, Roberts CT, Leroith D, Morey-Holton E (1994) Expression of the genes for insulin-like growth factors and their receptors in bone during skeletal growth. Am J Physiol 267:E278–E286
Meng A, Tang H, Yuan B, Ong BA, Long Q, Lin S (1999) Positive and negative cis-acting elements are required for hematopoietic expression of zebrafish GATA-1. Blood 93:500–508
Eckfeldt CE, Mendenhall EM, Flynn CM, Wang TF, Pickart MA, Grindle SM, Ekker SC, Verfaillie CM (2005) Functional analysis of human hematopoietic stem cell gene expression using zebrafish. PLoS Biol 3:e254
Burke AP, Virmani R (2007) Pathophysiology of acute myocardial infarction. Med Clin North Am 91:553–572
Gupta KB, Ratcliffe MB, Fallert MA, Edmunds LH Jr, Bogen DK (1994) Changes in passive mechanical stiffness of myocardial tissue with aneurysm formation. Circulation 89:2315–2326
Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E (1991) Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol Heart Circ Physiol 260:H1406–H1414
Raya TE, Gay RG, Lancaster L, Aguirre M, Moffett C, Goldman S (1988) Serial changes in left ventricular relaxation and chamber stiffness after large myocardial infarction in rats. Circulation 77:1424–1431
Paul S (2003) Ventricular remodeling. Crit Care Nurs Clin North Am 15:407–411
Samarel AM (2002) IGF-1 overexpression rescues the failing heart. Circ Res 90:631–633
Kinoshita T, Yokota T, Arai K, Miyajima A (1995) Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GMCSF receptors. EMBO J 14:266–275
Kinoshita T, Shirouzu M, Kamiya A, Hashimoto K, Yokoyama S, Miyajima A (1997) Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21 Ras in IL-3-dependent hematopoietic cells. Oncogene 15:619–627
Junghans D, Chauvet S, Buhler E, Dudley K, Sykes T, Henderson CE (2004) The CES-2-related transcription factor E4BP4 is an intrinsic regulator of motoneuron growth and survival. Development 131:4425–4434
Acknowledgment
We greatly appreciate Dr Jeffrey J. Y. Yen (Institute of Biomedical Sciences, Academia Sinica, Taiwan) for providing the E4BP4 plasmids.
Author information
Authors and Affiliations
Corresponding author
Additional information
James A. Lin, Chih-Yang Huang, and Kwong-Chung Tung contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Weng, YJ., Hsieh, D.JY., Kuo, WW. et al. E4BP4 is a cardiac survival factor and essential for embryonic heart development. Mol Cell Biochem 340, 187–194 (2010). https://doi.org/10.1007/s11010-010-0417-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-010-0417-6